• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    Biocon Gets US FDA Nod For Liraglutide Injection Saxenda

    EXPRESSPHARMA

    Biocon Targets Growth With Generic Weight-Loss Drugs

    REUTERS

    Biocon Arm Gets USFDA Nod For Generic Everolimus Tablets

    ECONOMICTIMES

    Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER

    INDPHARMAPOST

    Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug

    ECONOMICTIMES

    Biocon Aims to Launch Generic Wegovy in India by 2027, Says CEO

    ECONOMICTIMES

    Biocon Targets Canadian Market with Ozempic, Wegovy Generics

    ECONOMICTIMES

    Biocon Gets Approval for Diabetes Drug Liraglutide in India

    INDPHARMAPOST

    Biocon unit gets USFDA nod for generic drug

    ECONOMICTIMES

    Biocon seeks partner to test generic Wegovy, Ozempic in China

    MONEYCONTROL

    Biocon expands its Generic portfolio with the launch of Everolimus tablets

    EQUITYBULLS

    Biocon, DKSH to commercialize 7 generic formulations in SEA markets

    BIOSPECTRUMASIA

    Biocon And Mylan Get CRL From FDA For Lantus Rival

    PHARMAINTELLIGENCE

    Manufacturing cuts likely in remake of Sandoz

    FIERCE PHARMA

    ‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts

    FIERCE PHARMA

    Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical

    PATENT LITIGATION

    Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al

    PATENT LITIGATION

    Company Statement on US-FDA Inspection at Biocon Malaysia

    PRESS RELEASE

    Novartis and Biocon partner on ‘next wave’ of biosimilars

    FIERCE PHARMA

    Sun Pharma, Torrent, DRL & Lupin CLSA’s top pharma picks

    ECONOMIC TIMES

    Setback for Roche: Mylan, Biocon can now sell generics of its cancer drug

    BUSINESS-STANDARD

    Biosimilars: A shot in the arm for Biocon`s future prescription

    BUSINESS STANDARD

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.